Meeting Banner
Abstract #3122

Two-Year Serial Whole-Brain N-Acetylaspartate in Relapsing Remitting Multiple Sclerosis Patients

Daniel Rigotti1, Matilde Inglese1, Ivan Kirov1, Nissa Perry1, Joseph Herbert2, Robert I. Grossman1, Oded Gonen1

1Radiology, New York University School of Medicine, New York, NY, United States; 2Neurology, New York University School of Medicine, New York, NY, United States

We test the hypotheses that: relapsing-remitting (RR) MS patients exhibit quantifiable whole-brain N-acetylaspartate (WBNAA) decline, that is more sensitive than clinical changes; and may provide a practical outcomes for proof-of-concept trials. WBNAA was collected from 19 RR MS patients 335 years-old of 4728 months disease duration. Patients baseline WBNAA, 10.51.7mM, was significantly lower than controls 12.31.3mM-(p0.002) and declined significantly (5%/year- p0.002) while controls did not (0.4%/year-p0.7). Similarly, patients brain volume declined significantly (0.5%/year- p0.0001, controls:0.2%/year-p=0.08) with no significant EDSS changes. These results indicate that WBNAA is a longitudinally sensitive marker for neurodegeneration and may be suitable for larger multi-center trials.

Keywords

absolute accepted accurate accurately address adults aged amount annual approved avails better brain cause caused cells chiefly chronic clear clinical clinically concentration consent considered control controls correlate course cover cross decline declined decreasing depicting despite detect diagnosed diffuse disability disease disorder disparity distributions dividing duration dysfunction efficacy entire feedback fully good granular health healthy heterogeneous important indicate indicating individual integrity intervals irreversible issue lesion load loads localized localizing longer loss manifest marker markers matched measured measuring mechanism median medicine methodology metrics middle might month months moreover much neural neurological neurology neuronal newly note oded ongoing outcome overall patient patients period plots predict prevalent previous primary proton quantifiable quartiles radiology reflect reflected relapsing remains remitting report represent school sclerosis sectionally semiannual sensitively serial shorter significantly similarly since sites stable studies subjects subsequent take temporal third traumatic treatment uncertain undetected versus viability volume volumes whether whiskers whole widely women written year years young